Revenue | ₹14,948.23Cr |
Net Profits | ₹3,117.95Cr |
Net Profit Margins | 20.86% |
Sun Pharmaceutical Industries Ltd’s revenue jumped 9.55% since last year same period to ₹14,948.23Cr in the Q2 2025-2026. On a quarterly growth basis, Sun Pharmaceutical Industries Ltd has generated 4.42% jump in its revenue since last 3-months.
Sun Pharmaceutical Industries Ltd’s net profit jumped 2.56% since last year same period to ₹3,117.95Cr in the Q2 2025-2026. On a quarterly growth basis, Sun Pharmaceutical Industries Ltd has generated 36.83% jump in its net profits since last 3-months.
Sun Pharmaceutical Industries Ltd’s net profit margin fell -6.38% since last year same period to 20.86% in the Q2 2025-2026. On a quarterly growth basis, Sun Pharmaceutical Industries Ltd has generated 31.05% jumped in its net profit margins since last 3-months.
The revenue for Sun Pharmaceutical Industries Ltd in the Q2 results 2025 was ₹14,948.23Cr.
The net profit for Sun Pharmaceutical Industries Ltd in the Q2 results 2025 was ₹3,117.95Cr.
The net profit margin for Sun Pharmaceutical Industries Ltd in the Q2 results 2025 was 20.86%.
The revenue for Sun Pharmaceutical Industries Ltd in the Q2 results 2024 was ₹13,645.39Cr.
The net profit for Sun Pharmaceutical Industries Ltd in the Q2 results 2024 was ₹3,040.16Cr.
The net profit margin for Sun Pharmaceutical Industries Ltd in the Q2 results 2024 was 22.28%.